Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

8.
10.

Cooperative clofibrate trial.

Vaisrub S.

JAMA. 1979 Jun 15;241(24):2638. No abstract available.

PMID:
374769
11.

Cholesterol, coronaries, clofibrate and death.

Oliver MF.

N Engl J Med. 1978 Dec 14;299(24):1360-2. No abstract available.

PMID:
362204
12.

Review of clinical trials: proving the lipid hypothesis.

Brown WV.

Eur Heart J. 1990 Dec;11 Suppl H:15-20. Review.

PMID:
2073909
13.

Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around.

Fejfar Z.

Cor Vasa. 1979;21(6):377-9. No abstract available.

PMID:
397875
14.

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.

Coronary Drug Project Research Group.

N Engl J Med. 1980 Oct 30;303(18):1038-41.

PMID:
6999345
15.

Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, Shih J, Stamler J, Wentworth D.

Arch Intern Med. 1992 Jul;152(7):1490-500.

PMID:
1627030
16.

Clofibrate and niacin in coronary heart disease.

[No authors listed]

JAMA. 1975 Jan 27;231(4):360-81. No abstract available.

PMID:
1088963
17.

Clofibrate and the primary prevention of ischaemic heart disease.

[No authors listed]

Br Med J. 1978 Dec 9;2(6152):1585-6. No abstract available.

18.

Lipid lowering and ischaemic heart disease.

Oliver MF.

Acta Med Scand Suppl. 1981;651:285-93.

PMID:
6948505
19.

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ.

N Engl J Med. 1995 Nov 16;333(20):1301-7.

Supplemental Content

Support Center